Selank Peptide Pen -10mg

Peptide Name

Selank

CAS Number

• CAS Registry Number: 129954-34-3

Research Areas of Focus

Researchers are actively investigating Selank across several key neurological and physiological domains, including:

• Anxiolytic Pathways and Stress Mitigation: Investigating its potential to modulate generalized anxiety and stress-related behaviors in animal models without inducing traditional sedative, benzodiazapine-like, or muscle-relaxing side effects.

• Neurotransmitter Balance and Monoamine Metabolism: Evaluating its ability to influence the central nervous system by altering the metabolism of serotonin (5-HT) and norepinephrine, particularly within the hippocampus and prefrontal cortex.

• Neurotrophic Factor Expression and Synaptic Plasticity: Studying its capacity to stimulate the mRNA expression of Brain-Derived Neurotrophic Factor (BDNF), thereby theoretically supporting neuronal survival, memory consolidation, and neuroplastic repair.

• Enkephalinase Inhibition and Endogenous Opioid Regulation: Assessing the peptide’s role as an inhibitor of enzymes that degrade enkephalins, which may prolong the activity of natural pain-modulating and mood-regulating peptides in the brain.

• Immunomodulatory Response under Stress: Exploring the connection between the nervous and immune systems (neuroimmunology) by studying Selank’s ability to regulate cytokine levels, such as interleukin-6 (IL-6), during acute stress states.

RESEARCH-USE NOTICE

This product is supplied by Biolabs for laboratory and research purposes only. It is not intended to diagnose, treat, cure, or prevent any medical condition and should not be used as a substitute for professional medical advice or treatment.

Any information provided is for general research, product identification, storage, and handling purposes only. The purchaser is responsible for using and storing the product appropriately and in accordance with applicable regulations.